ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study) A Randomized Clinical Trial

Pahwa Rajesh; Tanner Caroline M.; Hauser Robert A.; Isaacson Stuart H.; Nausieda Paul A.; Truong Daniel D.; Agarwal Pinky; Hull Keith L.; Lyons Kelly E.; Johnson Reed; Stempien Mary Jean

首页> 外文期刊>JAMA neurology >ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study) A Randomized Clinical Trial

【24h】

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study) A Randomized Clinical Trial

机译：ADS-5102（Amantadine）百佳肽诱导的帕金森病（简易液化研究）延长释放胶囊（易于覆盖研究）随机临床试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

IMPORTANCE Medical treatment of levodopa-induced dyskinesia (LID) in Parkinson disease (PD) is an unmet need.

机译：在帕金森病（PD）中左旋多巴诱导的止咳瘤（盖子）的重要性医疗是一个未满足的需求。

著录项

来源
《JAMA neurology》 |2017年第8期|共9页
作者
Pahwa Rajesh; Tanner Caroline M.; Hauser Robert A.; Isaacson Stuart H.; Nausieda Paul A.; Truong Daniel D.; Agarwal Pinky; Hull Keith L.; Lyons Kelly E.; Johnson Reed; Stempien Mary Jean;
展开▼
作者单位

Univ Kansas Med Ctr Dept Neurol 3599 Rainbow Blvd Mailstop 3042 Kansas City KS 66160 USA;

Univ Calif San Francisco Dept Neurol San Francisco CA USA;

Univ S Florida Hlth Byrd Parkinsons Dis &

Movement Disorders Ctr Tampa FL USA;

Parkinsons Dis &

Movement Disorders Ctr Boca Rato Boca Raton FL USA;

Wisconsin Inst Neurol &

Sleep Disorders Milwaukee WI USA;

Parkinsons &

Movement Disorder Inst Fountain Valley CA USA;

Evergreen Hlth Booth Gardner Parkinsons Care Ctr Kirkland WA USA;

Raleigh Neurol Associates Raleigh NC USA;

Univ Kansas Med Ctr Dept Neurol 3599 Rainbow Blvd Mailstop 3042 Kansas City KS 66160 USA;

Adamas Pharmaceut Inc Emeryville CA USA;

Adamas Pharmaceut Inc Emeryville CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study) A Randomized Clinical Trial [J] . Pahwa Rajesh, Tanner Caroline M., Hauser Robert A., JAMA neurology . 2017,第8期

机译：ADS-5102（Amantadine）百佳肽诱导的帕金森病（简易液化研究）延长释放胶囊（易于覆盖研究）随机临床试验
2. Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease [J] . Elmer Lawrence W., Juncos Jorge L., Singer Carlos, CNS drugs . 2018,第4期

机译：ADS-5102（Amantadine）延长释放胶囊的AIC III研究的合并分析帕金森病的止吐剂
3. Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease (vol 32, pg 387, 2018) [J] . Elmer Lawrence W., Juncos Jorge L., Singer Carlos, CNS drugs . 2018,第4期

机译：ADS-5102（Amantadine）延长释放胶囊在帕金森病的延长释放胶囊的汇总分析（Vol 32，PG 387,2018）
4. On automated assessment of Levodopa-induced dyskinesia in Parkinson's disease [C] . Tsipouras Markos G., Tzallas Alexandros T., Fotiadis Dimitrios I., 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2011

机译：对左旋多巴诱发的帕金森病运动障碍的自动评估
5. Objective Vision-Based Assessment of Parkinsonism and Levodopa-Induced Dyskinesia in Persons with Parkinson's Disease. [D] . Li, Michael. 2017

机译：客观的基于视觉的帕金森氏病患者帕金森病和左旋多巴诱发的运动障碍评估。
6. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study [O] . Robert A. Hauser, Rajesh Pahwa, Caroline M. Tanner, -1

机译：ADS-5102（金刚烷胺）延缓释放胶囊用于帕金森氏病中左旋多巴诱发的运动障碍（EASE LID 2研究）：一项开放标签安全性研究的中期结果
7. Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia [O] . Robert A. Hauser, Shyamal H. Mehta, Daniel Kremens, 2021

机译：GOCOVRI（Amantadine）延长释放胶囊对帕金森病和止吐剂的日常生活经验的运动方面的影响

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study) A Randomized Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅